Binding characteristics of a radiolabeled agonist and antagonist at central nervous system alpha noradrenergic receptors.

Binding of the alpha noradrenergic agonist [3H]clonidine and the alpha antagonist [3H]WB-4101 (2-([29,69-dimethoxy]phenoxyethylamino)methylbenzodioxan) to rat brain membranes exhibits characteristics expected of alpha receptors for norepinephrine. Binding of both [3H]ligands is saturable, with KD values of 5.8 nM and 0.48 nM for [3H]clonidine and [3H]WB-4101, respectively. A series of catecholamines inhibits the binding of both ligands with the potency order epinephrine > norepinephrine >> isoproterenol, corresponding to the relative activities of these agents at alpha receptors in the periphery. Competition for binding is stereoselective, with (-) isomers of phenylethanolamines many times more potent than the corresponding (+) isomers. Classical alpha antagonists inhibit binding of both ligands at low concentrations, but beta antagonists are much weaker. Alpha agonists are more potent in displacing [3H]clonidine than [3H]WB-4101 binding, while alpha antagonists compete more avidly for [3H]WB-4101 sites. Partial agonist ergot alkaloids display similar affinities for the binding sites of both [3H]ligands. These findings may be explained by the existence of discrete agonist and antagonist states of the alpha receptor, which preferentially bind [3H]clonidine and [3H]WB-4101, respectively. Regional variations in the binding of both [3H]ligands in the brain are not pronounced, although levels tend to be highest in hypothalamus and cerebral cortex and lowest in cerebellum. Treatment with 6-hydroxydopamine fails to decrease the binding of either [3H]ligand, suggesting that binding occurs to postsynaptic sites.

• Publication year

  1977

• Venue

  Molecular Pharmacology

• Publication date

  1977-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/s0026-895x(25)11222-4PMID 17827
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Relative pre- and postsynaptic potencies of α-adrenoceptor agonists in the rabbit pulmonary artery

  2004cited by this paper
• Alpha-adrenergic receptor identification by (3H)dihydroergocryptine binding.

  1976cited by this paper
• Neurotransmitter receptors in the brain: biochemical identification.

  1976cited by this paper
• Association of high affinity stereospecific binding of 3H-propranolol to cerebral membranes with β adrenoceptors

  1976cited by this paper
• Binding of agonists and antagonists to muscarinic receptors.

  1976cited by this paper
• Alpha-noradrenergic receptor binding in mammalian brain: differential labeling of agonist and antagonist states.

  1976cited by this paper
• Properties of [3H]haloperidol and [3H]dopamine binding associated with dopamine receptors in calf brain membranes.

  1976cited by this paper
• Beta adrenergic receptor binding in membrane preparations from mammalian brain.

  1976cited by this paper
• beta-Adrenergic receptor involvement in 6-hydroxydopamine-induced supersensitivity in rat cerebral cortex.

  1976cited by this paper
• Serotonin and lysergic acid diethylamide binding in rat brain membranes: relationship to postsynaptic serotonin receptors.

  1976cited by this paper
• Stimulation of adenosine 3',5'-monophosphate formation by alpha and beta adrenergic agonists in rat cerebral cortical slices: effects of clonidine.

  1975cited by this paper
• Direct identification and characterisation of β-adrenergic receptors in rat brain

  1975cited by this paper
• Alpha adrenergic and histaminergic effects of tolazoline-like imidazolines.

  1975cited by this paper
• The alpha-adrenoceptor blocking effects of a new benzodioxane.

  1975cited by this paper
• Release of norepinephrine and dopamine-beta-hydroxylase by nerve stimulation. I. Role of neuronal and extraneuronal uptake and of alpha presynaptic receptors.

  1974cited by this paper
• Presynaptic regulation of catecholamine release.

  1974cited by this paper
• The use of desipramine in studies of noradrenergic nerve function

  1974cited by this paper
• Inhibition of adrenergic neurotransmission by clonidine: an action on prejunctional -receptors.

  1973cited by this paper
• CATECHOLAMINES IN FETAL AND NEWBORN RAT BRAIN

  1973cited by this paper
• On the analysis of pharmacological experiments in terms of an allosteric receptor model.

  1973cited by this paper
• Evidence for an alpha-sympathomimetic component in the effects of catapresan on vasomotor centres: antagonism by piperoxane.

  1971cited by this paper
• EFFECTS OF 6‐HYDROXYDOPAMINE ON CATECHOLAMINE CONTAINING NEURONES IN THE RAT BRAIN

  1970cited by this paper
• Pharmacological characteristics of adrenergic receptors.

  1970cited by this paper
• Comparative effects of dihydroergotamine and noradrenaline on resistance, exchange and capacitance functions in the peripheral circulation.

  1970cited by this paper
• Antiparkinsonian Drugs: Inhibition of Dopamine Uptake in the Corpus Striatum as a Possible Mechanism of Action

  1969cited by this paper
• Demethylimipramine (desipramine), an alpha-adrenergic blocking agent.

  1967cited by this paper
• On the application of "a plausible model" of allosteric proteins to the receptor for acetylcholine.

  1967cited by this paper
• Identification of the smooth muscle excitatory receptors for ergot alkaloids.

  1962cited by this paper
• The use of the rat's isolated seminal vesicle for the assay of sympatholytic drugs.

  1954cited by this paper

• Identification of Psychoplastogenic Tropanes Lacking Muscarinic Activity.

  2024cites this paper
• Adrenoceptors: Receptors, Ligands and Their Clinical Uses, Molecular Pharmacology and Assays.

  2024cites this paper
• Methamphetamine-Associated Cardiomyopathy: Addressing the Clinical Challenges.

  2022cites this paper
• Experimental strategies to discover and develop the next generation of psychedelics and entactogens as medicines.

  2022cites this paper
• Structure-Based Drug Design of Bisubstrate Inhibitors of Phenylethanolamine N-Methyltransferase Possessing Low Nanomolar Affinity at Both Substrate Binding Domains1.

  2020cites this paper
• PLATELET ALPHA, ADRENORECEPTORS ARE DECREASED IN NUMBER AFTER ANTIDEPRRSSANT THERAPY

  2020cites this paper
• Imidazoline Receptor System: The Past, the Present, and the Future

  2020cites this paper
• Clinical Study Protocol

  2020cites this paper
• Methamphetamine Use and Cardiovascular Disease.

  2019cites this paper
• In Search of Answers

  2019cites this paper
• Pericytes impair capillary blood flow and motor function after chronic spinal cord injury

  2017cites this paper
• The Discriminative Stimulus Properties of Drugs Used to Treat Depression and Anxiety.

  2016cites this paper
• emerging therapeutic potential of transdermal clonidine: a prospective as an adaptogen

  2015cites this paper
• emerging therapeutic potential of transdermal clonidine: a prospective as an adaptogen

  2015cites this paper
• Evaluation of AaDOP2 Receptor Antagonists Reveals Antidepressants and Antipsychotics as Novel Lead Molecules for Control of the Yellow Fever Mosquito, Aedes aegypti

  2015cites this paper
• Emerging therapeutic potential of transdermal clonidine: a prospective as an adaptogen

  2015cites this paper
• Anatomical and functional evidence for trace amines as unique modulators of locomotor function in the mammalian spinal cord

  2014cites this paper
• Optimization and Development of In Vitro Bioassays to Determine Structure-Activity Relationships for Cannabinoid Receptor 1 and Cannabinoid Receptor 2

  2012cites this paper
• α- and β-Adrenergic Receptor Subtypes

  2012cites this paper
• Adrenergic receptors modulate motoneuron excitability, sensory synaptic transmission and muscle spasms after chronic spinal cord injury.

  2011cites this paper
• Chronic administration of the anabolic androgenic steroid nandrolone alters neurosteroid action at the sigma-1 receptor but not at the sigma-2 or NMDA receptors.

  2011influential citation
• Trace amine-associated receptor 1 is a stereoselective binding site for compounds in the amphetamine class.

  2011cites this paper
• Muscle Spasms After Chronic Spinal Cord Injury Excitability , Sensory Synaptic Transmission and Adrenergic Receptors Modulate Motoneuron

  2011cites this paper
• EFFECTS OF ƒ¿-METHYLDOPA, CLONIDINE AND HYDRALAZINE ON NOREPINEPHRINE AND EPINEPHRINE SYNTHESIZING ENZYMES IN THE BRAINSTEM NUCLEI OF SPONTANEOUSLY HYPERTENSIVE RATS

  2010cites this paper
• Allosteric modulation of the NMDA receptor by neurosteroids in rat brain and the impact of long term morphine administration.

  2010cites this paper
• Endothelin modulates the cardiovascular effects of clonidine in the rat.

  2010cites this paper
• Presynaptic and transynaptic mechanisms involved in the subsensitivity of rat cortical noradrenergic system after long-term antidepressant treatment.

  2009cites this paper
• Regulation of serotonin neurotransmission by antidepressant drugs and electroconvulsive shock: the fall and rise of serotonin receptors.

  2009cites this paper
• Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy 69 Neurosteroids Induce Allosteric Effects on the NMDA Receptor Nanomolar Concentrations of Neurosteroids Exert Non-Genomic Effects on the NMDA Receptor Complex

  2008cites this paper
• The Pharmacology of Lysergic Acid Diethylamide: A Review

  2008cites this paper
• Cross-Talk between Dopaminergic and Noradrenergic Systems in the Rat Ventral Tegmental Area, Locus Ceruleus, and Dorsal Hippocampus

  2008cites this paper
• Synthesis of 4,5,6,7-tetrahydrothieno[3,2-c]pyridines and comparison with their isosteric 1,2,3,4-tetrahydroisoquinolines as inhibitors of phenylethanolamine N-methyltransferase.

  2008cites this paper
• Molecular Mechanisms for Nanomolar Concentrations of Neurosteroids at NR1/NR2B Receptors

  2008cites this paper
• Neurosteroids allosterically modulate the ion pore of the NMDA receptor consisting of NR1/NR2B but not NR1/NR2A.

  2008cites this paper
• D-Lysergic Acid Diethylamide (LSD) Investigator's Brochure

  2008cites this paper
• EVIDENCE FOR oe-ADRENOCEPTOR TWO IN DISTINCTVASCULAR TYPES OF POSTSYNAPTIC SMOOTH MUSCLE in vivo

  2007cites this paper
• Exploring the active site of phenylethanolamine N-methyltransferase with 1,2,3,4-tetrahydrobenz[h]isoquinoline inhibitors.

  2007cites this paper
• CHANGES IN a-ADRENERGIC RECEPTORS IN RAT BRAIN IN VITRO BY PREINCUBATION WITH a-ADRENERGIC LIGANDS

  2006cites this paper
• The ac1-adrenoceptor antagonist profile of doxazosin: preclinical pharmacology

  2006cites this paper
• ON THE SUPPRESSING EFFECT OF ISOPROTERENOL ON THE IMMOBILITY-REDUCING ACTION OF DESIPRAMINE IN THE FORCED SWIMMING TEST

  2006cites this paper
• DIFFERENTIAL INFLUENCES OF SEVERAL (k-ADRENOCEPTOR ANTAGONISTS ON «-ADRENOCEPTOR-MEDIATED INOTROPIC RESPONSES IN THE LEFT ATRIA OF GUINEA PIGS*

  2006cites this paper
• Comparison of the binding of 3-fluoromethyl-7-sulfonyl-1,2,3,4-tetrahydroisoquinolines with their isosteric sulfonamides to the active site of phenylethanolamine N-methyltransferase.

  2006cites this paper
• ROLE OF ƒ ¿-ADRENERGIC RECEPTORS IN DENERVATION SUPERSENSITIVITY OF RAT VAS DEFERENS

  2006cites this paper
• DEVELOPMENTAL CHANGES IN a-ADRENERGIC AND MUSCARINIC RECEPTOR-MEDIATED CONTRACTIONS OF RAT VAS DEFERENS

  2006cites this paper
• Application of the Goldilocks effect to the design of potent and selective inhibitors of phenylethanolamine N-methyltransferase: balancing pKa and steric effects in the optimization of 3-methyl-1,2,3,4-tetrahydroisoquinoline inhibitors by beta-fluorination.

  2006cites this paper
• Pharmac . ( 1979 ) , 65 , 663-670 THE CHARACTERISTICS OF [ 3 H ]-CLONIDINE BINDING TO AN ca-ADRENOCEPTOR IN MEMBRANES FROM GUINEA-PIG KIDNEY

  2006cites this paper
• Effects of Clonidine , ƒ ¿-Methyldopa and Hydralazine on Met-Enkephalinergic Neurons in Cerebral Nuclei of Spontaneously Hypertensive Rats

  2006cites this paper
• Systemic phenoxybenzamine but not β-adrenergic antagonists block noradrenergic inhibition of cerebellar Purkinje and hippocampal pyramidal neurons

  2005cites this paper
• Exploring the active site of phenylethanolamine N-methyltransferase: 3-alkyl-7-substituted-1,2,3,4-tetrahydroisoquinoline inhibitors.

  2005cites this paper
• Biochemical, behavioural, and endocrine effects of CK 204-933, a novel 8β-ergolene

  2005cites this paper
• 3-hydroxymethyl-7-(N-substituted aminosulfonyl)-1,2,3,4-tetrahydroisoquinoline inhibitors of phenylethanolamine N-methyltransferase that display remarkable potency and selectivity.

  2005cites this paper
• ai-Adrenergic Receptor Binding in the Spontaneously Hypertensive Rat

  2005cites this paper
• A comparison of various antidepressant drugs demonstrates rapid desensitisation of α2-adrenoceptors exclusively by sibutramine hydrochloride

  2005cites this paper
• Nanomolar inhibitors of CNS epinephrine biosynthesis: (R)-(+)-3-fluoromethyl-7-(N-substituted aminosulfonyl)-1,2,3,4-tetrahydroisoquinolines as potent and highly selective inhibitors of phenylethanolamine N-methyltransferase1.

  2005cites this paper
• The C 1 area of the brainstem in tonic and reflex control of blood pressure . State of the art

  2005cites this paper
• Cardiovascular actions of kynuramine and 5-hydroxykynuramine in pithed rats

  2005cites this paper
• Thyroid hormone and norepinephrine: Effects on alpha-2, beta, and reuptake sites in cerebral cortex and heart

  2005cites this paper
• Locomotor activity and catecholamine receptor binding in adult normotensive and spontaneously hypertensive rats

  2005cites this paper
• Exploring the active site of phenylethanolamine N-methyltransferase with 3-hydroxyethyl- and 3-hydroxypropyl-7-substituted-1,2,3,4-tetrahydroisoquinolines.

  2005cites this paper
• Noradrenaline-stimulated inositol phospholipid breakdown as a measure of alpha1-adrenoceptor function in rat hippocampal miniprisms after repeated antidepressant treatment

  2005cites this paper
• Alpha-Adrenergic Receptors in Rat Myocardium Identification by Binding of [ 3 H ]

  2005cites this paper
• How Does Salt Raise Blood Pressure?

  2005cites this paper
• Inhibitors of phenylethanolamine N-methyltransferase devoid of alpha2-adrenoceptor affinity.

  2005cites this paper
• Lesioning of serotoninergic and noradrenergic nerve fibres of the rat brain does not decrease binding of 3H-clonidine and 3H-rauwolscine to cortical membranes

  2004cites this paper
• Proceedings of the British Pharmacological Society

  2004cites this paper
• Inhibitors of phenylethanolamine N-methyltransferase that are predicted to penetrate the blood-brain barrier: design, synthesis, and evaluation of 3-fluoromethyl-7-(N-substituted aminosulfonyl)-1,2,3,4-tetrahydroisoquinolines that possess low affinity toward the alpha2-adrenoceptor.

  2004cites this paper
• Changes in noradrenergic neuroendocrine responses following repeated seizures and the mechanism of action of ECT

  2004cites this paper
• Role of hydrophobicity on the monoamine receptor binding affinities of central nervous system drugs: a quantitative retention-activity relationships analysis using biopartitioning micellar chromatography.

  2004cites this paper
• Alpha noradrenergic receptors in brain membranes: Sodium, magnesium and guanyl nucleotides modulate agonist binding

  2004cites this paper
• Anxiolytics antagonize yohimbine's discriminative stimulus properties

  2004cites this paper
• Elucidation of the structure and receptor binding studies of the major primary, metabolite of dihydroergotamine in man

  2004cites this paper
• Haloperidol facilitates memory retrieval in the rat

  2004cites this paper
• The Receptor Concept : A Continuing Evolution 326

  2004cites this paper
• Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitor

  2004cites this paper
• Modulation of rat brain α-adrenoreceptor populations four weeks after stimulation of the nucleus locus coeruleus

  2004cites this paper
• Hallucinogens.

  2004cites this paper
• Studies on YM-12617: A selective and potent antagonist of postsynaptic α1-adrenoceptors

  2004cites this paper
• The role of different types of adrenergic receptors in phentylenetetrazol-induced seizures and the effect of di-n-propylacetate in the rat

  2004cites this paper
• The receptor concept: a continuing evolution.

  2004cites this paper
• Clinical investigations into antidepressive mechanisms

  2004cites this paper
• Differences in presynaptic α-blockade, noradrenaline uptake inhibition, and potential antidepressant activity between (+)- and (-)mianserin

  2004cites this paper
• The motor effects of bromocriptine — a review

  2004cites this paper
• A study of the possible influence of central 5-HT function on clonidine-induced hypoactivity responses in mice

  2004cites this paper
• Molecular electrostatic potential as a factor of drug–receptor recognition

  2003cites this paper
• Synthesis and evaluation of 4-fluoro-8-substituted-2,3,4,5-tetrahydro-1H-2-benzazapines as selective inhibitors of phenylethanolamine N-methyltransferase versus the alpha(2)-adrenoceptor.

  2001cites this paper
• Effects of a 3-alkyl-, 4-hydroxy- and/or 8-aromatic-substituent on the phenylethanolamine N-methyltransferase inhibitor potency and alpha2-adrenoceptor affinity of 2,3,4,5-tetrahydro-1H-2-benzazepines.

  2001cites this paper
• Inorganic iron complexes derived from the nitric oxide donor nitroprusside: competitive N-methyl-D-aspartate receptor antagonists with nanomolar affinity.

  2001cites this paper
• Role of Serotoninergic Neurons and 5-HT Receptors in the Action of Hallucinogens

  2000cites this paper
• High and low responders to novelty: effects of adrenergic agents on the regulation of accumbal dopamine under challenged and non-challenged conditions.

  2000cites this paper
• Modulation of sibutramine‐induced increases in extracellular noradrenaline concentration in rat frontal cortex and hypothalamus by α2‐adrenoceptors

  1999cites this paper
• PATHOGENESIS OF HEPATIC ENCEPHALOPATHY - A ROLE FOR THE BENZODIAZEPINE RECEPTOR ?

  1999cites this paper
• 1,3-Dimethyl-7-substituted-1,2,3,4-tetrahydroisoquinolines as probes for the binding orientation of tetrahydroisoquinoline at the active site of phenylethanolamine N-methyltransferase.

  1999cites this paper
• Synthesis and evaluation of 3-trifluoromethyl-7-substituted-1,2,3, 4-tetrahydroisoquinolines as selective inhibitors of phenylethanolamine N-methyltransferase versus the alpha(2)-adrenoceptor.

  1999cites this paper
• 3,7-Disubstituted-1,2,3,4-tetrahydroisoquinolines display remarkable potency and selectivity as inhibitors of phenylethanolamine N-methyltransferase versus the alpha2-adrenoceptor.

  1999cites this paper
• Synthesis, biochemical evaluation, and classical and three-dimensional quantitative structure-activity relationship studies of 7-substituted-1,2,3,4-tetrahydroisoquinolines and their relative affinities toward phenylethanolamine N-methyltransferase and the alpha2-adrenoceptor.

  1999cites this paper
• Synthesis and biochemical evaluation of 3-fluoromethyl-1,2,3, 4-tetrahydroisoquinolines as selective inhibitors of phenylethanolamine N-methyltransferase versus the alpha(2)-adrenoceptor.

  1999cites this paper
• Enantiospecific synthesis of 3-fluoromethyl-, 3-hydroxymethyl-, and 3-chloromethyl-1,2,3,4-tetrahydroisoquinolines as selective inhibitors of phenylethanolamine N-methyltransferase versus the alpha(2)-adrenoceptor.

  1999cites this paper
• PROFILES OF THE AFFINITY OF ANTIPSYCHOTIC DRUGS FOR NEUROTRANSMITTER RECEPTORS AND THEIR CLINICAL IMPLICATION

  1998cites this paper
• Effect of beta-adrenergic agents on intracellular potential of rabbit ciliary epithelium.

  1998cites this paper
• PST2238: a new antihypertensive compound that antagonizes the long-term pressor effect of ouabain.

  1998cites this paper